Form4insider filings, from the source

SEC Form 4 · accession 0001019687-15-003240

US-China Biomedical Technology, Inc. · UCBB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Zhen Mu
Officer — Secretary · Director
Period of report
Jun 1, 2015
Accepted (ET)
Aug 21, 2015 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516079

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 1, 2015P1,000$1.48A2,560D
Common StockF1Jun 23, 2015P520$1.90A3,080D
Common StockF1Jul 9, 2015P100$4.15A3,180D
Common StockF1Jul 10, 2015P4,900$4.20A8,080D
Common StockF1Jul 13, 2015P1,650$4.45A9,730D
Common StockF1Jul 14, 2015P3,273$4.45A13,003D
Common StockF1Jul 15, 2015P77$3.50A13,080D
Common StockF1Aug 3, 2015P230$7.20A13,310D
Common StockF1Aug 3, 2015P1,205$8.00A14,515D
Common StockF1Aug 3, 2015P250$6.30A14,765D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

On August 21, 2015, Zhen Mu resigned from all officer and director positions held in the Company, effective immediately.